Literature DB >> 30865819

Hypertension Hot Potato - Anatomy of the Angiotensin-Receptor Blocker Recalls.

J Brian Byrd1, Glenn M Chertow1, Vivek Bhalla1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30865819      PMCID： PMC7066505          DOI： 10.1056/NEJMp1901657

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

1.  Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.

Authors:  Paul Muntner; Robert M Carey; Samuel Gidding; Daniel W Jones; Sandra J Taler; Jackson T Wright; Paul K Whelton
Journal:  J Am Coll Cardiol       Date:  2017-11-13       Impact factor: 24.094
  1 in total
  10 in total

1.  Changes in Utilization of Generic Angiotensin Receptor Blockers Following Product Recalls in the United States.

Authors:  Rishi J Desai; Ameet Sarpatwari; Nileesa Gautam; Joyce Lii; Michael A Fischer; Joshua J Gagne
Journal:  JAMA       Date:  2020-01-07       Impact factor: 56.272

Review 2.  Current Status of Angiotensin Receptor Blocker Recalls.

Authors:  Pradeep Moon Gunasekaran; Glenn M Chertow; Vivek Bhalla; James Brian Byrd
Journal:  Hypertension       Date:  2019-10-21       Impact factor: 10.190

3.  Development of a Sensitive Headspace Gas Chromatography-Mass Spectrometry Method for the Simultaneous Determination of Nitrosamines in Losartan Active Pharmaceutical Ingredients.

Authors:  Wisut Wichitnithad; Orawan Sudtanon; Pawadee Srisunak; Kamonrak Cheewatanakornkool; Siriwan Nantaphol; Pornchai Rojsitthisak
Journal:  ACS Omega       Date:  2021-04-16

4.  Identification and Development of Therapeutics for COVID-19.

Authors:  Halie M Rando; Nils Wellhausen; Soumita Ghosh; Alexandra J Lee; Anna Ada Dattoli; Fengling Hu; James Brian Byrd; Diane N Rafizadeh; Ronan Lordan; Yanjun Qi; Yuchen Sun; Christian Brueffer; Jeffrey M Field; Marouen Ben Guebila; Nafisa M Jadavji; Ashwin N Skelly; Bharath Ramsundar; Jinhui Wang; Rishi Raj Goel; YoSon Park; Simina M Boca; Anthony Gitter; Casey S Greene
Journal:  mSystems       Date:  2021-11-02       Impact factor: 6.496

5.  Utilization of Generic Cardiovascular Drugs in Medicare's Part D Program.

Authors:  Iris Ma; Rebecca L Tisdale; Daniel Vail; Paul A Heidenreich; Alexander T Sandhu
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2021-12-09

Review 6.  Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension?

Authors:  Jeffrey M Turner; Ravi Kodali
Journal:  Curr Cardiol Rep       Date:  2020-07-09       Impact factor: 2.931

Review 7.  Antihypertensive agents: a long way to safe drug prescribing in children.

Authors:  Nida Siddiqi; Ibrahim F Shatat
Journal:  Pediatr Nephrol       Date:  2019-11-01       Impact factor: 3.651

8.  Identification and Development of Therapeutics for COVID-19.

Authors:  Halie M Rando; Nils Wellhausen; Soumita Ghosh; Alexandra J Lee; Anna Ada Dattoli; Fengling Hu; James Brian Byrd; Diane N Rafizadeh; Yanjun Qi; Yuchen Sun; Jeffrey M Field; Marouen Ben Guebila; Nafisa M Jadavji; Ronan Lordan; Ashwin N Skelly; Bharath Ramsundar; Christian Brueffer; Jinhui Wang; Rishi Raj Goel; YoSon Park; Simina M Boca; Anthony Gitter; Casey S Greene
Journal:  ArXiv       Date:  2021-03-03

9.  Extent of a valsartan drug shortage and its effect on antihypertensive drug use in the Canadian population: a national cross-sectional study.

Authors:  Jennifer Fenna; Cherry Chu; Rola Hassan; Tara Gomes; Mina Tadrous
Journal:  CMAJ Open       Date:  2021-12-07

10.  Impact of national valsartan recalls on Veterans' outcomes.

Authors:  Paige L Morizio; Sara R Britnell; Andreina A Ottman
Journal:  Ther Adv Drug Saf       Date:  2021-06-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.